StockNews.com started coverage on shares of CASI Pharmaceuticals ( NASDAQ:CASI – Free Report ) in a research report sent to investors on Tuesday morning. The brokerage issued a hold rating on the biotechnology company's stock. CASI Pharmaceuticals Stock Performance CASI opened at $2.51 on Tuesday. CASI Pharmaceuticals has a twelve month low of $1.45 and a twelve month high of $4.86. The firm's 50-day moving average price is $2.55 and its 200 day moving average price is $2.38. CASI Pharmaceuticals ( NASDAQ:CASI – Get Free Report ) last issued its earnings results on Wednesday, May 17th.

https://www.dailypolitical.com/2023/08/04/stocknews-com-begins-coverage-on-casi-pharmaceuticals-nasdaqcasi.html

#dailypolitical